| Code | CSB-MP6357MOV1 |
| Abbreviation | Recombinant Cynomolgus monkey LYPD3 protein, partial (Active) |
| MSDS | |
| Size | $138 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
LYPD3 serves as a cell surface marker implicated in tumor progression and metastasis, making it a relevant target for cancer biology investigations. This cynomolgus macaque ortholog, spanning residues 32–293 and produced in mammalian cells to preserve native glycosylation, demonstrates robust antibody-binding activity with an EC50 of 0.88–1.69 ng/mL in functional ELISA, confirming its suitability for antibody screening, epitope mapping studies, and immunoassay development. The protein meets the purity and endotoxin criteria typical for binding assays and cell-based functional studies, with >95% purity by SDS-PAGE and <1.0 EU/μg endotoxin. Researchers developing therapeutic antibodies against LYPD3 or investigating its role in oncogenic signaling pathways can use this reagent as a positive control in ELISA platforms or as an immobilized ligand for characterizing antibody–antigen interactions in preclinical cancer research.
There are currently no reviews for this product.